Theravance Biopharma Inc (TBPH) Stock Price, Quote, News & History

TBPHNASDAQ
$17.03
At close: Sep 24, 5:00 PM EST
$17.04
0.0140.08%
After Hours: Sep 23, 5:58 PM EST
M&A: Theravance Biopharma (TBPH) was acquired by Zymeworks (ZYME) on Wednesday, September 23, 2026 for $929M paid in cash

Theravance Biopharma (TBPH) Stock Price, Quote, News & History | Benzinga

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
53.74M
Investing Cash Flow (TTM)
-107.47M
Financing Cash Flow (TTM)
-8.44M
Free Cash Flow (TTM)
53.73M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-62.16M

Analyst Trends and Forecast

1
Apr
1
Jun
1
Jul
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.3
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$535.09M
PE Ratio (TTM)
16.38
PE Ratio (FWD)
9.73
PEG Ratio (TTM)
-
PS Ratio (TTM)
8.47
PB Ratio (TTM)
3.05
Earnings Yield % (TTM)
6.11%
Earnings Yield % (FWD)
10.28%
EV / EBITDA (TTM)
8.60
Price / EBITDA (TTM)
14.20
Price / Free Cash Flow (TTM)
16.45
Book Value / Share
$5.58

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$219.77M
Debt to Equity
0.13
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 863.61K
Day Range
- - -
52 Wk Range
13.08 - 21.03
Market Cap
$884.90M
P/E Ratio
16.38
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
4.98%
Days to Cover
4.54

About

Sector
Health Care
Industry
Pharmaceuticals
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalatio...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Theravance Biopharma (TBPH) stock?

A

You can purchase shares of Theravance Biopharma (NASDAQ:TBPH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Theravance Biopharma (TBPH) competitors?

Q

What is the forecast, or price target, for Theravance Biopharma (TBPH) stock?

A

Theravance Biopharma has a consensus price target of $14.75.

Q

What is the current price for Theravance Biopharma (TBPH)?

A

The stock price for Theravance Biopharma (NASDAQ: TBPH) is $17.044 last updated September 23, 2026 at 5:58 PM EDT.

Q

Does Theravance Biopharma (TBPH) pay a dividend?

A

There are no upcoming dividends for Theravance Biopharma.

Q

When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?

A

Theravance Biopharma does not have any upcoming earnings scheduled.

Q

Is Theravance Biopharma (TBPH) going to split?

A

There is no upcoming split for Theravance Biopharma.

Q

What sector and industry does Theravance Biopharma (TBPH) operate in?

A

Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.